Treating critically ill anaemic patients with erythropoietin: why not?

被引：0
|
作者：
Sigismond Lasocki
Antoine Kimmoun
Gerald Chanques
Lionel Velly
Frédéric Pène
机构：
[1] Université d’Angers,Département Anesthésie Réanimation
[2] CHU Angers,Service de Médecine Intensive et Réanimation
[3] Université de Lorraine,Département Anesthésie Réanimation, Hopital Saint
[4] CHRU de Nancy,Éloi Hospital, Et PhyMedExp, INSERM, CNRS
[5] Inserm U1116,Service d’Anesthésie Réanimation
[6] Brabois,MeCA, Institut de Neurosciences de La Timone, UMR 7289
[7] Université de Montpellier,Service de Médecine Intensive et Réanimation, Hôpital Cochin, Assistance Publique
[8] APHM,Hôpitaux de Paris Centre
[9] CHU Timone,undefined
[10] Aix Marseille Université,undefined
[11] Université de Paris,undefined
来源：
Intensive Care Medicine | 2020年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1794 / 1795
页数：1
相关论文
共 50 条
  • [31] Efficacy of recombinant erythropoietin in the critically ill
    Corwin, HL
    Gettinger, A
    INTENSIVE CARE MEDICINE, 2002, 28 : S160 - S160
  • [32] Anemia in the critically Ill: The role of erythropoietin
    Corwin, HL
    SEMINARS IN HEMATOLOGY, 2001, 38 (03) : 24 - 32
  • [33] Why does cholecystokinin increase in critically ill patients?
    Asai, Takashi
    CRITICAL CARE MEDICINE, 2007, 35 (01) : 298 - 299
  • [34] Why is Acinetobacter baumannii a problem for critically ill patients?
    Marin H. Kollef
    Michael S. Niederman
    Intensive Care Medicine, 2015, 41 : 2170 - 2172
  • [35] Why is Acinetobacter baumannii a problem for critically ill patients?
    Kollef, Marin H.
    Niederman, Michael S.
    INTENSIVE CARE MEDICINE, 2015, 41 (12) : 2170 - 2172
  • [36] Thromboprophylaxis in critically ill patients: When? Why? How?
    Prat, G.
    Delluc, A.
    Renault, A.
    Lacut, K.
    REANIMATION, 2011, 20 (02): : 118 - 123
  • [37] INFLAMMATORY CYTOKINES, ERYTHROPOIETIN, AND ANEMIA AMONG CRITICALLY ILL SEPTIC PATIENTS
    Loftus, Tyler
    Ozrazgat-Baslanti, Tezcan
    Brakenridge, Scott
    Mira, Juan
    Efron, Philip
    Moore, Frederick
    Moldawer, Lyle
    Mohr, Alicia
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [38] Response to the randomized trial of recombinant human erythropoietin in critically ill patients
    Belova, Eva
    Kanna, Balavenkatesh
    CRITICAL CARE MEDICINE, 2007, 35 (06) : 1632 - 1632
  • [39] Outcomes with the Use of Recombinant Human Erythropoietin in Critically Ill Burn Patients
    Lundy, Jonathan B.
    Hetz, Katherine
    Chung, Kevin K.
    Renz, Evan M.
    White, Christopher E.
    King, Booker T.
    Huzar, Todd
    Wolf, Steven E.
    Blackbourne, Lorne H.
    AMERICAN SURGEON, 2010, 76 (09) : 951 - 956
  • [40] Population pharmacokinetics of erythropoietin in critically ill subjects
    Chakraborty, A
    Natarajan, J
    Guilfoyle, M
    Morgan, N
    Vercammen, E
    Cheung, W
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (02): : 193 - 202
12345